13 research outputs found

    Π­ΠšΠ‘ΠŸΠ•Π Π˜ΠœΠ•ΠΠ’ΠΠ›Π¬ΠΠžΠ• И ΠšΠ›Π˜ΠΠ˜Π§Π•Π‘ΠšΠžΠ• ΠžΠ‘ΠžΠ‘ΠΠžΠ’ΠΠΠ˜Π• ΠŸΠ Π˜ΠœΠ•ΠΠ•ΠΠ˜Π― Π­Π›Π•ΠšΠ’Π ΠžΠœΠΠ“ΠΠ˜Π’ΠΠ«Π₯ Π’ΠžΠ›Π Π’Π•Π ΠΠ“Π•Π Π¦Π•Π’ΠžΠ“Πž Π”Π˜ΠΠŸΠΠ—ΠžΠΠ НА ЧАБВОВАΠ₯ Π˜Π—Π›Π£Π§Π•ΠΠ˜Π― И ΠŸΠžΠ“Π›ΠžΠ©Π•ΠΠ˜Π― ΠžΠšΠ‘Π˜Π”Π ΠΠ—ΠžΠ’Π И ΠšΠ˜Π‘Π›ΠžΠ ΠžΠ”Π ПРИ Π ΠΠ—Π›Π˜Π§ΠΠ«Π₯ ЀОРМАΠ₯ ΠŸΠΠ’ΠžΠ›ΠžΠ“Π˜Π˜

    Get PDF
    Most of the abiotic environmental factors are electromagnetic in nature. Electromagnetic radiation from various artificial sources exerts a significant inf luence on living systems. It poses a problem of targeted application of electromagnetic waves in health care, ever yday life, and industr y. Recently, a fundamentally new direction in medicine has emerged: the use of low-power terahertz electromagnetic waves at the frequency of oscillation of active cellular metabolites (nitrogen oxide, molecular oxygen, etc.) for disease treatment and prevention. It has been demonstrated that if there is a match in frequency bet ween the emitted electromagnetic wave and the natural oscillation of the molecule, absorption occurs and this alters the amplitude of the molecular oscillation and modifies involvement of the molecule in the metabolic process. This fact is of great interest for biomedical technologies because cellular metabolites may significantly affect regional circulation, microcirculation, and blood rheology; prevent intravascular coagulation; provide anti-inf lammator y and analgesic effects; limit excessive lipid peroxidation and potentiate the antioxidant mechanism; activate cellular anti-stress mechanisms. Today,Β  terahertz electromagnetic radiation at the frequency of oscillation of nitric oxide, a universal cellular regulator y molecule, has been shown to be beneficial in the treatment of cardiovascular diseases, burns, polyneuropathy, regional pain syndrome, etc. This review summarizes clinical and experimental data on implementation of terahertz electromagnetic waves in medicine and presents our current understanding of the mechanisms of action of terahertz electromagnetic waves at the frequency of oscillation of active cellular metabolites on a living system at the molecular, cellular, tissue, and organ levels of organization.Π‘ΠΎΠ»ΡŒΡˆΠΈΠ½ΡΡ‚Π²ΠΎ абиотичСских Ρ„Π°ΠΊΡ‚ΠΎΡ€ΠΎΠ² внСшнСй срСды, ΠΈΠ³Ρ€Π°ΡŽΡ‰ΠΈΡ… ΡΡƒΡ‰Π΅ΡΡ‚Π²Π΅Π½Π½ΡƒΡŽ Ρ€ΠΎΠ»ΡŒ Π² процСссах ΠΆΠΈΠ·Π½Π΅Π΄Π΅ΡΡ‚Π΅Π»ΡŒΠ½ΠΎΡΡ‚ΠΈ Ρ‡Π΅Π»ΠΎΠ²Π΅ΠΊΠ°, ΠΈΠΌΠ΅ΡŽΡ‚ ΡΠ»Π΅ΠΊΡ‚Ρ€ΠΎΠΌΠ°Π³Π½ΠΈΡ‚Π½ΡƒΡŽ ΠΏΡ€ΠΈΡ€ΠΎΠ΄Ρƒ. Π’ биосфСрС элСктромагнитныС колСбания Ρ€Π°Π·Π»ΠΈΡ‡Π½Ρ‹Ρ… частот ΠΎΠ±Π»Π°Π΄Π°ΡŽΡ‚ Ρ€Π°Π·Π½Ρ‹ΠΌΠΈ ΠΈΠ½Ρ„ΠΎΡ€ΠΌΠ°Ρ†ΠΈΠΎΠ½Π½Ρ‹ΠΌΠΈ ΠΈ энСргСтичСскими свойствами. Π˜ΡΠΊΡƒΡΡΡ‚Π²Π΅Π½Π½Ρ‹Π΅ источники элСктромагнитных ΠΊΠΎΠ»Π΅Π±Π°Π½ΠΈΠΉ способны ΠΎΠΊΠ°Π·Ρ‹Π²Π°Ρ‚ΡŒ воздСйствиС Π½Π° ΠΆΠΈΠ²Ρ‹Π΅ систСмы. Π­Ρ‚ΠΎ ставит Π·Π°Π΄Π°Ρ‡Ρƒ поиска возмоТностСй ΠΈΡ… Ρ†Π΅Π»Π΅Π½Π°ΠΏΡ€Π°Π²Π»Π΅Π½Π½ΠΎΠ³ΠΎ примСнСния Π² клиничСской ΠΏΡ€Π°ΠΊΡ‚ΠΈΠΊΠ΅,Β  Π±Ρ‹Ρ‚Ρƒ ΠΈ ΠΏΡ€ΠΎΠΌΡ‹ΡˆΠ»Π΅Π½Π½ΠΎΡΡ‚ΠΈ. Π­Π»Π΅ΠΊΡ‚Ρ€ΠΎΠΌΠ°Π³Π½ΠΈΡ‚Π½Ρ‹Π΅ Π²ΠΎΠ»Π½Ρ‹ ΠΊΡ€Π°ΠΉΠ½Π΅ высокой частоты ΡƒΠΆΠ΅ ΡƒΡΠΏΠ΅ΡˆΠ½ΠΎ ΠΏΡ€ΠΈΠΌΠ΅Π½ΡΡŽΡ‚ Π² комплСксном Π»Π΅Ρ‡Π΅Π½ΠΈΠΈ Ρ€Π°Π·Π»ΠΈΡ‡Π½Ρ‹Ρ… ΡΠΎΡ†ΠΈΠ°Π»ΡŒΠ½ΠΎ Π·Π½Π°Ρ‡ΠΈΠΌΡ‹Ρ… Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉ Ρ‡Π΅Π»ΠΎΠ²Π΅ΠΊΠ°. Π’ послСдниС Π³ΠΎΠ΄Ρ‹ ΡΠΊΡΠΏΠ΅Ρ€ΠΈΠΌΠ΅Π½Ρ‚Π°Π»ΡŒΠ½ΠΎ ΠΈ тСорСтичСски обосновано ΠΏΡ€ΠΈΠ½Ρ†ΠΈΠΏΠΈΠ°Π»ΡŒΠ½ΠΎ Π½ΠΎΠ²ΠΎΠ΅ Π½Π°ΠΏΡ€Π°Π²Π»Π΅Π½ΠΈΠ΅ Π² ΠΌΠ΅Π΄ΠΈΡ†ΠΈΠ½Π΅ ΠΈ Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΠΈ β€” ΠΏΡ€ΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ элСктромагнитного излучСния Ρ‚Π΅Ρ€Π°Π³Π΅Ρ€Ρ†Π΅Π²ΠΎΠ³ΠΎ Π΄ΠΈΠ°ΠΏΠ°Π·ΠΎΠ½Π° ΠΌΠ°Π»ΠΎΠΉ мощности с Ρ‚ΠΎΠΉ ΠΆΠ΅ частотой молСкулярного спСктра поглощСния ΠΈ излучСния, Ρ‡Ρ‚ΠΎ ΠΈ Ρƒ биологичСски Π°ΠΊΡ‚ΠΈΠ²Π½Ρ‹Ρ… ΠΌΠΎΠ»Π΅ΠΊΡƒΠ» β€” СстСствСнных рСгуляторов Ρ„ΡƒΠ½ΠΊΡ†ΠΈΠΉ ΠΎΡ€Π³Π°Π½ΠΈΠ·ΠΌΠ°. Π˜Π·Π²Π΅ΡΡ‚Π½ΠΎ, Ρ‡Ρ‚ΠΎ ΠΎΡ‚Π΄Π΅Π»ΡŒΠ½Ρ‹Π΅ биологичСски Π°ΠΊΡ‚ΠΈΠ²Π½Ρ‹Π΅ ΠΌΠΎΠ»Π΅ΠΊΡƒΠ»Ρ‹, Ρ‚Π°ΠΊΠΈΠ΅ ΠΊΠ°ΠΊ оксид Π°Π·ΠΎΡ‚Π° ΠΈ кислород, ΠΎΠ±Π»Π°Π΄Π°ΡŽΡ‚ ΡΠΏΠΎΡΠΎΠ±Π½ΠΎΡΡ‚ΡŒΡŽ ΠΈΠ·ΠΌΠ΅Π½ΡΡ‚ΡŒ ΡƒΡ€ΠΎΠ²Π΅Π½ΡŒ Ρ€Π΅Π³ΠΈΠΎΠ½Π°Ρ€Π½ΠΎΠ³ΠΎ кровообращСния ΠΈ микроциркуляции, рСологичСскиС свойства ΠΊΡ€ΠΎΠ²ΠΈ, Π² Ρ‚ΠΎΠΌ числС ΠΏΡ€ΠΈ Ρ€Π°Π·Π»ΠΈΡ‡Π½Ρ‹Ρ… заболСваниях; ΠΏΡ€Π΅ΠΏΡΡ‚ΡΡ‚Π²ΠΎΠ²Π°Ρ‚ΡŒ внутрисосудистому ΡΠ²Π΅Ρ€Ρ‚Ρ‹Π²Π°Π½ΠΈΡŽ ΠΊΡ€ΠΎΠ²ΠΈ ΠΈ Ρ‚Ρ€ΠΎΠΌΠ±ΠΎΠ·Ρƒ; ΠΎΠΊΠ°Π·Ρ‹Π²Π°Ρ‚ΡŒ ΠΏΡ€ΠΎΡ‚ΠΈΠ²ΠΎΠ²ΠΎΡΠΏΠ°Π»ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΠ΅ ΠΈ ΠΎΠ±Π΅Π·Π±ΠΎΠ»ΠΈΠ²Π°ΡŽΡ‰Π΅Π΅ дСйствиС; ΠΎΠ³Ρ€Π°Π½ΠΈΡ‡ΠΈΠ²Π°Ρ‚ΡŒ ΠΈΠ·Π±Ρ‹Ρ‚ΠΎΡ‡Π½ΡƒΡŽ ΠΈΠ½Ρ‚Π΅Π½ΡΠΈΠ²Π½ΠΎΡΡ‚ΡŒ ΡΠ²ΠΎΠ±ΠΎΠ΄Π½ΠΎΡ€Π°Π΄ΠΈΠΊΠ°Π»ΡŒΠ½ΠΎΠ³ΠΎ пСрСкисного окислСния  Π»ΠΈΠΏΠΈΠ΄ΠΎΠ²Β  ΠΈΒ  Π°ΠΊΡ‚ΠΈΠ²ΠΈΡ€ΠΎΠ²Π°Ρ‚ΡŒΒ  Ρ„Π°ΠΊΡ‚ΠΎΡ€Ρ‹ с антиоксидантной Π°ΠΊΡ‚ΠΈΠ²Π½ΠΎΡΡ‚ΡŒΡŽ;Β  ΠΎΠ±Π΅ΡΠΏΠ΅Ρ‡ΠΈΠ²Π°Ρ‚ΡŒ ΡΡ‚Ρ€Π΅ΡΡΠ»ΠΈΠΌΠΈΡ‚ΠΈΡ€ΡƒΡŽΡ‰ΠΈΠΉΒ  эффСкт.Β  Π’Π΅Ρ€Π°Π³Π΅Ρ€Ρ†Π΅Π²Ρ‹Π΅Β  Π²ΠΎΠ»Π½Ρ‹Β  с  частотой  ΠΊΠΎΠ»Π΅Π±Π°Π½ΠΈΠΉΒ  молСкулярного  спСктра поглощСния ΠΈ излучСния оксида Π°Π·ΠΎΡ‚Π° ΠΈΡΠΏΠΎΠ»ΡŒΠ·ΡƒΡŽΡ‚ΡΡ Π² практичСском Π·Π΄Ρ€Π°Π²ΠΎΠΎΡ…Ρ€Π°Π½Π΅Π½ΠΈΠΈ (ΠΏΡ€ΠΈ Π»Π΅Ρ‡Π΅Π½ΠΈΠΈ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉ сСрдСчно-сосудистой систСмы, ΠΎΠΆΠΎΠ³ΠΎΠ², ΠΏΠΎΠ»ΠΈΠ½Π΅ΠΉΡ€ΠΎΠΏΠ°Ρ‚ΠΈΠΉ, Ρ€Π΅Π³ΠΈΠΎΠ½Π°Ρ€Π½ΠΎΠ³ΠΎ Π±ΠΎΠ»Π΅Π²ΠΎΠ³ΠΎ синдрома ΠΈ Π΄Ρ€.) с Ρ…ΠΎΡ€ΠΎΡˆΠΈΠΌ тСрапСвтичСским эффСктом. Π’ настоящСС врСмя интСнсивно ΠΈΠ·ΡƒΡ‡Π°ΡŽΡ‚ΡΡ эффСкты дСйствия элСктромагнитных Π²ΠΎΠ»Π½ Ρ‚Π΅Ρ€Π°Π³Π΅Ρ€Ρ†Π΅Π²ΠΎΠ³ΠΎ Π΄ΠΈΠ°ΠΏΠ°Π·ΠΎΠ½Π° с частотами элСктромагнитных ΠΊΠΎΠ»Π΅Π±Π°Π½ΠΈΠΉ биологичСски Π°ΠΊΡ‚ΠΈΠ²Π½Ρ‹Ρ… ΠΌΠΎΠ»Π΅ΠΊΡƒΠ» Π½Π° ΠΆΠΈΠ²Ρ‹Π΅ систСмы, Π° Ρ‚Π°ΠΊΠΆΠ΅ ΠΌΠ΅Ρ…Π°Π½ΠΈΠ·ΠΌΡ‹ Ρ€Π΅Π°Π»ΠΈΠ·Π°Ρ†ΠΈΠΈ этих эффСктов Π½Π° молСкулярном, ΠΊΠ»Π΅Ρ‚ΠΎΡ‡Π½ΠΎΠΌ ΠΈ ΠΎΡ€Π³Π°Π½Π½ΠΎ-Ρ‚ΠΊΠ°Π½Π΅Π²ΠΎΠΌ уровнях ΠΎΡ€Π³Π°Π½ΠΈΠ·Π°Ρ†ΠΈΠΈ биосистСм. ИмСнно этим ΠΏΡ€ΠΎΠ±Π»Π΅ΠΌΠ°ΠΌ посвящСн настоящий ΠΎΠ±Π·ΠΎΡ€ Π»ΠΈΡ‚Π΅Ρ€Π°Ρ‚ΡƒΡ€Π½Ρ‹Ρ… Π΄Π°Π½Π½Ρ‹Ρ… послСдних 15 Π»Π΅Ρ‚

    Transport and magnetotransport properties of cold-pressed CrO2_2 powder, prepared by hydrothermal synthesis

    Full text link
    Submicron powder of CrO2_2 was prepared by hydrothermal synthesis method from chromium trioxide. Particles obtained were of rounded form with mean diameter about 120 nm. The powder (stabilized with thin surface layer of \beta-CrOOH) has been characterized by structural, X-ray and magnetic measurements. The powder (with Curie temperature about 385 K) was cold-pressed and its transport and magnetotransport properties have been measured in the temperature range 4--450 K in magnetic field up to 1.6 T. The samples studied is characterized by non-metallic temperature behavior of resistance and large negative magnetoresistance (MR) in low temperature range. At T=5 K the MR magnitude has been -17% at H=0.3 T and -20% at H=1.4 T. Its magnitude decreased fast with increase in temperature reducing to 0.3% and less for T>200 K. It is shown that this MR behavior is inherent for a system of magnetic grains with spin-dependent intergrain tunnelling. Some peculiarities of MR behavior in low-temperature range (below 40 K) can be associated with percolating character of tunnelling conductivity of this granular system under conditions of availability of only few conducting current paths through the sample.Comment: 21 pages (including 9 separate figures), submitted to J. of Alloys and Compound

    Effect of Anesthesia on Postoperative Pain in Patients after Septoplasty

    No full text
    Abstract: The aim of the study was to assess acute pain syndrome in patients after septoplasty using different tactics of general anesthesia. All patients received local anesthesia with 2% procaine solution. In group 1 (95Β patients), premedication with 2% promedol solution and 60 mg of ketorolac in the evening was used; group 2 (72 patients) was administered with fentanyl, propofol, cisatracuria besylate, tranexamic acid, atropine, and metoclopramide; and group 3 (89 patients) received atracuria besylate, sodium thiopental, nitrous oxide, and halothane. In groups 2 and 3, 100 mg of ketoprofen was administered intramuscularly in the evening on the day of surgery. Anterior tamponade was performed with parolon tampons in glove rubber. In groups 1 and 2, the tamponade was removed on day 2, and in group 3 it was removed 1 day after surgery. Pain syndrome was assessed on 1, 3, and 6 h and on days 1 and 2 after surgery. It was found that the scheme of anesthesia in group 2 is the most preferable, and the nasal tamponade must be removed on the 2nd day after the surgery. Β© 2022, Pleiades Publishing, Ltd

    COVID-19 VIRUS-POSITIVE PATIENTS AFTER LARINGECTOMY: TREATMENT IN A HOSPITAL

    No full text
    The coronavirus pandemic is spreading rapidly around the world. The health systems of all countries faced extraordinary problems in terms of the creation and distribution of medical resources, including the re-equipment and creation of new hospital beds, and the provision of personal protective equipment. The patients who undergo a laryngectomy are a special category. Given the fact that during the operation they have a separation of the upper and lower respiratory tract, in the context of the COVID-19 pandemic, such patients require special attention from oncologists and otorhinolaryngologists. Purpose of the study is to review the characteristics of patient management after a laryngectomy in a COVID-19 pandemic. Laryngectomy patients represent a unique contingent in conditions of coronavirus infection SARS-COV-2, it is advisable to focus on providing them with protective equipment. This will significantly reduce the risk of infection with their virus, which can be a deadly threat to them. Infected patients during an epidemic represent a potential source of infection for medical personnel, which requires special protective measures. All procedures associated with the replacement of the prosthesis, endoscopic manipulations, it is advisable to postpone until the normalization of the epidemiological situation. If carrying out such operations is vital, then they should be carried out, observing all necessary precautions for both the patient and medical personnel

    Hybrid Sigma Filter for Processing Images Corrupted by Multiplicative Noise

    No full text

    The nonlinear resilient functions from binary block codes

    No full text
    Π Π°ΡΡΠΌΠ°Ρ‚Ρ€ΠΈΠ²Π°ΡŽΡ‚ΡΡ ΠΌΠ΅Ρ‚ΠΎΠ΄Ρ‹ построСния Π½Π΅Π»ΠΈΠ½Π΅ΠΉΠ½Ρ‹Ρ… ΡƒΠ·Π»ΠΎΠ² Π·Π°ΠΌΠ΅Π½ симмСтричных криптографичСских Π°Π»Π³ΠΎΡ€ΠΈΡ‚ΠΌΠΎΠ², ΠΈΡΡΠ»Π΅Π΄ΡƒΡŽΡ‚ΡΡ ΠΏΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»ΠΈ ΠΈ ΠΊΡ€ΠΈΡ‚Π΅Ρ€ΠΈΠΈ ΠΈΡ… эффСктивности. РассматриваСтся ΠΌΠ΅Ρ‚ΠΎΠ΄ построСния Π½Π΅Π»ΠΈΠ½Π΅ΠΉΠ½Ρ‹Ρ… эластичных Ρ„ΡƒΠ½ΠΊΡ†ΠΈΠΉ ΠΈΠ· Π΄Π²ΠΎΠΈΡ‡Π½Ρ‹Ρ… Π»ΠΈΠ½Π΅ΠΉΠ½Ρ‹Ρ… Π±Π»ΠΎΡ‡Π½Ρ‹Ρ… ΠΊΠΎΠ΄ΠΎΠ², анализируСтся ΠΏΠ΅Ρ€ΡΠΏΠ΅ΠΊΡ‚ΠΈΠ²Π½ΠΎΡΡ‚ΡŒ Π΄Π°Π½Π½ΠΎΠ³ΠΎ ΠΌΠ΅Ρ‚ΠΎΠ΄Π° для получСния Ρ„ΡƒΠ½ΠΊΡ†ΠΈΠΉ с ΡƒΠ»ΡƒΡ‡ΡˆΠ΅Π½Π½Ρ‹ΠΌΠΈ показатСлями стойкости. Π˜ΡΡΠ»Π΅Π΄ΡƒΡŽΡ‚ΡΡ свойства синтСзируСмых Π±ΡƒΠ»Π΅Π²Ρ‹Ρ… Ρ„ΡƒΠ½ΠΊΡ†ΠΈΠΉ ΠΏΠΎ Ρ€Π°Π·Π»ΠΈΡ‡Π½Ρ‹ΠΌ показатСлям стойкости. ΠžΡ†Π΅Π½ΠΈΠ²Π°Π΅Ρ‚ΡΡ достигаСмая Π½Π΅Π»ΠΈΠ½Π΅ΠΉΠ½ΠΎΡΡ‚ΡŒ ΠΈ ΡΠ»Π°ΡΡ‚ΠΈΡ‡Π½ΠΎΡΡ‚ΡŒ для Ρ„ΡƒΠ½ΠΊΡ†ΠΈΠΉ, ΠΏΠΎΠ»ΡƒΡ‡Π΅Π½Π½Ρ‹Ρ… ΠΈΠ· Ρ€Π°Π·Π»ΠΈΡ‡Π½Ρ‹Ρ… классов Π»ΠΈΠ½Π΅ΠΉΠ½Ρ‹Ρ… Π±Π»ΠΎΠΊΠΎΠ²Ρ‹Ρ… ΠΊΠΎΠ΄ΠΎΠ², проводятся сравнСния с Π΄Ρ€ΡƒΠ³ΠΈΠΌΠΈ ΠΌΠ΅Ρ‚ΠΎΠ΄Π°ΠΌΠΈ синтСза ΠΈ Π²Π΅Ρ€Ρ…Π½ΠΈΠΌΠΈ тСорСтичСскими Π³Ρ€Π°Π½ΠΈΡ†Π°ΠΌΠΈ для сбалансированных криптографичСских Ρ„ΡƒΠ½ΠΊΡ†ΠΈΠΉ.Π ΠΎΠ·Π³Π»ΡΠ΄Π°ΡŽΡ‚ΡŒΡΡ ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΈ ΠΏΠΎΠ±ΡƒΠ΄ΠΎΠ²ΠΈ Π½Π΅Π»Ρ–Π½Ρ–ΠΉΠ½ΠΈΡ… Π²ΡƒΠ·Π»Ρ–Π² Π·Π°ΠΌΡ–Π½ симСтричних ΠΊΡ€ΠΈΠΏΡ‚ΠΎΠ³Ρ€Π°Ρ„Ρ–Ρ‡Π½ΠΈΡ… Π°Π»Π³ΠΎΡ€ΠΈΡ‚ΠΌΡ–Π², Π΄ΠΎΡΠ»Ρ–Π΄ΠΆΡƒΡŽΡ‚ΡŒΡΡ ΠΏΠΎΠΊΠ°Π·Π½ΠΈΠΊΠΈ ΠΊΡ€ΠΈΡ‚Π΅Ρ€Ρ–Ρ— Ρ—Ρ… СфСктивності. Π ΠΎΠ·Π³Π»ΡΠ΄Π°Ρ”Ρ‚ΡŒΡΡ ΠΌΠ΅Ρ‚ΠΎΠ΄ ΠΏΠΎΠ±ΡƒΠ΄ΠΎΠ²ΠΈ Π½Π΅Π»Ρ–Π½Ρ–ΠΉΠ½ΠΈΡ… Сластичних Ρ„ΡƒΠ½ΠΊΡ†Ρ–Ρ— Π· Π΄Π²Ρ–ΠΉΠΊΠΎΠ²ΠΈΡ… Π»Ρ–Π½Ρ–ΠΉΠ½ΠΈΡ… Π±Π»ΠΎΠΊΠΎΠ²ΠΈΡ… ΠΊΠΎΠ΄Ρ–Π², Π°Π½Π°Π»Ρ–Π·ΡƒΡ”Ρ‚ΡŒΡΡ ΠΏΠ΅Ρ€ΡΠΏΠ΅ΠΊΡ‚ΠΈΠ²Π½Ρ–ΡΡ‚ΡŒ Π΄Π°Π½ΠΎΠ³ΠΎ ΠΌΠ΅Ρ‚ΠΎΠ΄Ρƒ для отримання Ρ„ΡƒΠ½ΠΊΡ†Ρ–ΠΉ Π· ΠΏΠΎΠ»Ρ–ΠΏΡˆΠ΅Π½ΠΈΠΌΠΈ ΠΏΠΎΠΊΠ°Π·Π½ΠΈΠΊΠ°ΠΌΠΈ стійкості. Π”ΠΎΡΠ»Ρ–Π΄ΠΆΡƒΡŽΡ‚ΡŒΡΡ властивості синтСзованих Π±ΡƒΠ»Π΅Π²ΠΈΡ… Ρ„ΡƒΠ½ΠΊΡ†Ρ–ΠΉ Π·Π° Ρ€Ρ–Π·Π½ΠΈΠΌΠΈ ΠΏΠΎΠΊΠ°Π·Π½ΠΈΠΊΠ°ΠΌΠΈ стійкості. ΠžΡ†Ρ–Π½ΡŽΡ”Ρ‚ΡŒΡΡ Π½Π΅Π»Ρ–Π½Ρ–ΠΉΠ½Ρ–ΡΡ‚ΡŒ, Ρ‰ΠΎ Π΄ΠΎΡΡΠ³Π°Ρ”Ρ‚ΡŒΡΡ, Ρ‚Π° Π΅Π»Π°ΡΡ‚ΠΈΡ‡Π½Ρ–ΡΡ‚ΡŒ для Ρ„ΡƒΠ½ΠΊΡ†Ρ–ΠΉ, ΠΎΡ‚Ρ€ΠΈΠΌΠ°Π½ΠΈΡ… Π· Ρ€Ρ–Π·Π½ΠΈΡ… класів Π»Ρ–Π½Ρ–ΠΉΠ½ΠΈΡ… Π±Π»ΠΎΠΊΠΎΠ²ΠΈΡ… ΠΊΠΎΠ΄Ρ–Π², ΠΏΡ€ΠΎΠ²ΠΎΠ΄ΡΡ‚ΡŒΡΡ порівняння Π· Ρ–Π½ΡˆΠΈΠΌΠΈ ΠΌΠ΅Ρ‚ΠΎΠ΄Π°ΠΌΠΈ синтСзу ΠΉ Π²Π΅Ρ€Ρ…Π½Ρ–ΠΌΠΈ Ρ‚Π΅ΠΎΡ€Π΅Ρ‚ΠΈΡ‡Π½ΠΈΠΌΠΈ ΠΌΠ΅ΠΆΠ°ΠΌΠΈ для збалансованих ΠΊΡ€ΠΈΠΏΡ‚ΠΎΠ³Ρ€Π°Ρ„Ρ–Ρ‡Π½ΠΈΡ… Ρ„ΡƒΠ½ΠΊΡ†Ρ–ΠΉ.Methods of creation of nonlinear nodes of changeovers of the symmetric cryptographic algorithms are considered, indexes and criteria of their efficiency are researched. The method of creation of nonlinear resilient functions from the binary linear block codes is considered, perspectivity of the given method for obtaining of functions with the improved indexes of security is analyzed. Properties of synthesizable Boolean functions on various indexes of security are researched. Nonlinearity and resilient for the functions which are received from various classes of the linear block codes is estimated. Make comparisons with other methods of synthesis and the upper theoretical boundaries for the balanced cryptography functions

    New lateral flow immunoassay for on-site detection of Erwinia amylovora and its application on various organs of infected plants

    No full text
    Erwinia amylovora causes a quarantine disease called fire blight that affects most plants from the Rosaceae family. An efficient and rapid disease diagnosis tool is needed to prevent the spread of the pathogen. The main objective of this study was to develop a lateral flow immunoassay (LFIA) to detect E. amylovora and compare different organs of plants for optimization of LFIA testing. A total of 11 strains of E. amylovora and related species were tested for specificity of the developed LFIA. The detection limit of E. amylovora was equal to 4 Γ— 105 CFU mLβˆ’1 in plant extracts. LFIA showed high specificity and did not demonstrate positive results with non-related species. Meanwhile, LFIA's effectiveness was confirmed through testing artificially infected leaf samples of apple, pear, and black raspberry. Reliable results were obtained 10 min after the start of LFIA for all testing strains. Different plant organs (121 samples) comprising apple, pear, hawthorn, quince, blackthorn, and cherry from naturally infected areas with symptoms of varying severity were tested. The LFIA was performed using samples from leaves, twigs, flowers, fruitlets, and bacterial ooze; for confirmation commercial kits based on fluorescent amplification–based specific hybridization PCR were used. Using several samples from one plant (cluster) significantly increased the accuracy of infected plant detection, the overlap of LFIA and PCR were equal to 70.2% for individual samples and 93.5% for clusters. Observed recovery of E. amylovora for different organs differed by up to 20%. We found out that using vascular tissues was better than using leaf extracts. This result demonstrates that LFIA's effectiveness improved when more appropriate samples were used. Β© 2021 Elsevier Lt

    ASSESSMENT OF THE EFFECT OF ANESTHESIA METHODS ON HRV AND PAIN SYNDROME AFTER SEPTOPLASTY

    No full text
    Aims: to evaluate various methods of anesthesia during septoplasty for changes in heart rate variability (HRV) and acute pain syndrome in the early postoperative period. Patients and methods. All patients received local anesthesia with 2% procaine solution. In group 1(105 people) premedication was used with 2% promedol solution and 60 mg of ketorolac in the evening, in group 2 (108 people) -fentanyl, propofol, cisatracuria besylate, tranexamic acid, atropine and metoclopramide, in group 3 (78 people) - atracuria besylate, sodium thiopental, nitrous oxide and halothane. In groups 2 and 3, 100 mg of ketoprofen was administered intramuscularly in the evening on the day of surgery. The frequency domain of HRV was estimated per day. Pain was assessed using a visual analogue scale (VAS). Results. ULF and LF were significantly higher in groups 2 and 3 than in the local anesthetic group. VLF in the second group was significantly lower than in groups 1 and 3. Groups 2 and 3 had low HF. The VHF of group 2 was significantly lower than in groups 1 and 3, which also differed from each other - the VHF values in group 1 were higher than in group 2. Total power in group 2 was significantly lower than in groups 1 and 3. Pain syndrome was less pronounced in group 2. Conclusion. The following scheme may be less stressful when performing septopalstics for general anesthesia: fentanyl, propofol, cisatracuria besylate, tranexamic acid, atropine and metoclopramide
    corecore